A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results
- PMID: 7037982
- DOI: 10.1093/infdis/145.3.292
A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results
Abstract
A controlled field trial of Salmonella typhi strain Ty 21a oral vaccine against typhoid was carried out in Alexandria, Egypt, from March 1978 to March 1981. A total of 32,388 children was included in the study. The children were divided in two comparable groups, one given three doses of vaccine and the other three doses of placebo. Each dose of vaccine contained 1-8 X 10(9) live Ty 21a bacteria. The population was monitored, and each suspected case of typhoid was investigated bacteriologically and serologically. The effectiveness of the vaccine was assessed by analyzing the number of confirmed cases of typhoid fever in the two groups. The incidence of typhoid fever was 4.9 cases per 10,000 children per year in the control group and 0.2 cases per 10,000 children per year in the vaccine group. The results indicate that, in the dose schedule used, the Ty 21a mutant strain, which is stable and safe, is protective for a period of at least three years.
Similar articles
-
A controlled field trial of liver oral typhoid vaccine Ty21a.Bull World Health Organ. 1980;58(3):469-74. Bull World Health Organ. 1980. PMID: 6998594 Free PMC article. Clinical Trial.
-
Inefficacy of the commercial live oral Ty 21a vaccine in the prevention of typhoid fever.Eur J Clin Microbiol. 1985 Jun;4(3):295-8. doi: 10.1007/BF02013656. Eur J Clin Microbiol. 1985. PMID: 4018068
-
Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.Lancet. 1991 Oct 26;338(8774):1055-9. doi: 10.1016/0140-6736(91)91910-m. Lancet. 1991. PMID: 1681365 Clinical Trial.
-
A review of the current status of enteric vaccines.P N G Med J. 1995 Dec;38(4):325-31. P N G Med J. 1995. PMID: 9522876 Review.
-
A new look at typhoid vaccination. Information for the practicing physician.JAMA. 1991 Feb 13;265(6):756-9. JAMA. 1991. PMID: 1990193 Review.
Cited by
-
Oral vaccination against enteric bacterial infections: an overview.Infection. 1985;13 Suppl 2:S206-10. doi: 10.1007/BF01644432. Infection. 1985. PMID: 3902655 Clinical Trial.
-
Immunoblot detection of class-specific humoral immune response to outer membrane proteins isolated from Salmonella typhi in humans with typhoid fever.J Clin Microbiol. 1989 Jul;27(7):1640-5. doi: 10.1128/jcm.27.7.1640-1645.1989. J Clin Microbiol. 1989. PMID: 2768450 Free PMC article.
-
Comparative analysis of immunological responses to oral (Ty21a) and parenteral (TAB) typhoid vaccines.Infect Immun. 1988 Oct;56(10):2731-5. doi: 10.1128/iai.56.10.2731-2735.1988. Infect Immun. 1988. PMID: 3417354 Free PMC article. Clinical Trial.
-
Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi.Infect Immun. 2007 Mar;75(3):1382-92. doi: 10.1128/IAI.00888-06. Epub 2006 Dec 18. Infect Immun. 2007. PMID: 17178790 Free PMC article.
-
Oral Typhoid Vaccination With Live-Attenuated Salmonella Typhi Strain Ty21a Generates Ty21a-Responsive and Heterologous Influenza Virus-Responsive CD4+ and CD8+ T Cells at the Human Intestinal Mucosa.J Infect Dis. 2016 Jun 1;213(11):1809-19. doi: 10.1093/infdis/jiw030. Epub 2016 Jan 24. J Infect Dis. 2016. PMID: 26810369 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources